课题基金 / 基金详情

Eastern Cooperative Oncology Group Chair's Office

Eastern Cooperative Oncology Group Chair's Office
东部肿瘤合作组主席办公室
批准号：
7262496
负责人：
ROBERT L COMIS
金额：
$64.45万
依托单位：
DREXEL UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
1999
资助国家：
美国
项目状态：
已结题
起止时间：
1999-09-22 至 2010-04-30
来源：
https://reporter.nih.gov/project-details/7262496
关键词：
ABT-627Access to InformationAcetatesAchievementActivity CyclesAcuteAcute Myelocytic LeukemiaAddendumAddressAdjuvantAdministratorAdoptedAdultAdverse eventAdvertisingAdvisory CommitteesAdvocacyAdvocateAfrican AmericanAgeAge-YearsAgreementAirAmendmentAngiogenesis InhibitorsAntineoplastic AgentsApoptosisAppearanceAppendixApplications GrantsAppointmentAreaAtrasentanAttentionAuthorization documentationAutologousAutologous Bone Marrow TransplantationAwardAwarenessBenefits and RisksBiological ProductsBiologyBirdsBlindedBone MarrowBostonBreastBudgetsBusinessesCD34 geneCSF3 geneCancer BiologyCancer CenterCancer PatientCancer Trials Support UnitCancer and Leukemia Group BCancer cell lineCarcinomaCaringCell LineCellsCertificate of ConfidentialityCertificationCharacteristicsChargeChemopreventionChildren&aposs Oncology GroupChromosome abnormalityChronicClassificationClinicClinicalClinical Cancer CenterClinical OncologyClinical Practice GuidelineClinical ResearchClinical TrialsClinical Trials Cooperative GroupClinical Trials Data Monitoring CommitteesClinical Trials DesignClosureCodeCollaborationsColorectal CancerCommitCommunicationCommunication ProgramsCommunitiesCommunity Clinical Oncology ProgramCommunity NetworksCommunity PhysicianComplexComputer SecurityConceptionsConditionConduct Clinical TrialsConfidentialityConfidentiality of Patient InformationConflict (Psychology)Conflict of InterestConsciousConsentConsent FormsConstitutionContractsControlled StudyCooperative Research and Development AgreementCorrelative StudyCounselingCountryCuesCyclosporinsCytarabineDailyDalteparinDataData ReportingData SourcesData Storage and RetrievalDatabasesDecision MakingDelawareDenileukin DiftitoxDevelopmentDevelopmental Therapeutics ProgramDexamethasoneDexamethasone/Doxorubicin/PSC 833/VincristineDiagnosisDiagnostic Neoplasm StagingDiarrheaDisclosureDiseaseDisease remissionDisseminated Malignant NeoplasmDocetaxel/DoxorubicinDocetaxel/EstramustineDocetaxel/IrinotecanDoctor of MedicineDoctor of PharmacyDoctor of PhilosophyDocumentationDoseDouble-Blind MethodDrug ApprovalDrug IndustryDrug usageEPO906 (Epothilone B-Novartis)Early DiagnosisEastern Cooperative Oncology GroupEducationEducational MaterialsEducational workshopEffectivenessElderlyElectronic MailElectronicsEmployee StrikesEmploymentEndometrial adenocarcinomaEndometriumEnrollmentEnsureEquilibriumEstramustineEstrogensEthicsEthnic OriginEuropeanEventFaceFacultyFederal GovernmentFellowshipFemaleFilgrastimFire - disastersFloridaFluorouracilFocus GroupsFood, Drug and Cosmetic ActFornet brand of tetrazepamFosteringFoundationsFruitFulvestrantFundingFunding OpportunitiesFutureGemtuzumab OzogamicinGenderGeneticGlioblastomaGoalsGovernmentGovernment regulationsGrantGray unit of radiation doseGroomingGroup MeetingsGroup StructureGrowthGuidelinesHandHead and Neck Squamous Cell CarcinomaHealthHealth FairsHealth Insurance Portability and Accountability ActHealth PlanningHealth StatusHealth educationHematologyHormone ReceptorHormonesHospitalsHumanHuman ResourcesHuman Subject ResearchHydrocortisone/KetoconazoleImatinibImmunoblastic LymphadenopathyImmunologicsIncidenceIndividualIndustryInformation DistributionInformed ConsentInjection of therapeutic agentInstitutesInstitutionInsurance CoverageIntellectual PropertyInterferonsInterleukin-11InternetInterphaseIntravenousInvestigational DrugsJob DescriptionJointsJournalsKnowledgeLabelLaboratoriesLaboratory ResearchLabyrinthLanguageLawyersLeadershipLegalLengthLicensingLifeLinkLiteratureLocal Area NetworksLogisticsLoperamideLymphoblastic LeukemiaMYB geneMaintenanceMalignant NeoplasmsMalignant neoplasm of prostateManufacturer NameMarimastatMarketingMeasuresMediationMedicalMedical centerMedicareMedicineMethodsMinorityMissionModalityModelingMolecularMonitorMonitoring Clinical TrialsMotexafin GadoliniumMovementMucoepidermoid CarcinomaMultiple MyelomaMyeloid LeukemiaNational Cancer InstituteNational Cancer Institute of Canada Clinical Trials GroupNational Surgical Adjuvant Breast and Bowel ProjectNatureNegative Axillary Lymph NodeNeoplasm MetastasisNew AgentsNew EnglandNewly DiagnosedNewsletterNucleotidesOccupational activity of managing financesOctreotideOctreotide Acetate SaltOffice for Human Research ProtectionsOperative Surgical ProceduresOprelvekinOutcomeOxidation-ReductionPamphletsPaperParticipantPathologyPathway interactionsPatient EducationPatient ParticipationPatient RepresentativePatientsPeer ReviewPemetrexedPemetrexed DisodiumPennsylvaniaPeptidesPerformancePersonsPharmaceutical PreparationsPharmacogeneticsPharmacogenomicsPharmacologic SubstancePharmacologyPhasePhase II Clinical TrialsPhase III Clinical TrialsPhiladelphiaPhilosophyPhysiciansPilot ProjectsPlacebosPlayPoliciesPopulationPositioning AttributePostmenopausePreparationPress ReleasesPreventionPrimary Care PhysicianPrincipal InvestigatorPrintingProceduresProcessProduct LabelingProductionProgesteroneProgram EvaluationProteinase-Activated ReceptorsProteomicsProto-Oncogene Proteins c-mybProtocols documentationPublic HealthPublic RelationsPublicationsPuerto RicoPurposeQualifyingQuality of lifeRaceRandomizedRandomized Clinical TrialsRandomized Controlled Clinical TrialsRangeRateRecombinantsRecommendationRecording of previous eventsRecordsRecurrenceRefractoryRegistered nurseRegulationRegulatory AffairsRelapseRelative (related person)Replacement TherapyReportingResearchResearch DesignResearch Ethics CommitteesResearch InfrastructureResearch PersonnelResearch Project GrantsResearch ProposalsResearch SupportResistanceResolutionResource AllocationResourcesRightsRiskRisk FactorsRoleRouteSDZ-PSC-833SafetyScheduleScienceScientistScreening procedureSecureSeleniumServicesSignal TransductionSignal Transduction InhibitionSiteSlideSodiumSolutionsSouth AfricaSouth AmericaSpeedStable DiseaseStaff DevelopmentStagingStandards of Weights and MeasuresState GovernmentStatutes and LawsStem cellsSteroidsStrategic PlanningStructureSuggestionSupplementationSupport GroupsSupport SystemSurveysSystemT-Cell LymphomaTamoxifenTechnologyTelephoneTelevisionThalidomideTherapeuticTherapeutic AgentsTherapeutics CommitteeThinkingTimeTitleTo specifyTodayTouch sensationToxic effectTrainingTraining and EducationTranslational ResearchTransplantationUSA GeorgiaUnderrepresented MinorityUnderserved PopulationUnited StatesUnited States Dept. of Health and Human ServicesUnited States Food and Drug AdministrationUnited States National Institutes of HealthUnited States Public Health ServiceUniversitiesUpdateVisionVotingWeekWestern Asia GeorgiaWisconsinWomanWorkWritingYeastsZD1839 (IRESSA)abstractingadvocacy organizationsanastrozoleanti-cancer therapeuticauthoritybasecancer carecancer preventioncancer therapychemotherapeutic agentchemotherapyclinically relevantcollegecomputerized data processingconceptcoralcostcytotoxicdata acquisitiondata managementdaydesigndesiredocetaxeldocument outlinesdosagedrug discoverydrug distributiondrug marketexperiencefallsfarnesyltranstransferasefollow-upfrontiergemcitabinegene therapyglucose transportgranulocytehealth care deliveryhormone therapyhuman subjecthydroxyureaimprovedinnovationinterestkidney celllectureslung small cell carcinomamacrophagemalemalignant breast neoplasmmalignant stomach neoplasmmembernewsnovelolder patientoncologyoutcome forecastpatient advocacy grouppatient orientedpaymentperformance sitepre-clinicalpressurepreventprogramsprospectiveprospectusesprotein farnesyltransferaseprotocol developmentresearch studyresponsesargramostimsoundstatistical centerstemsubcutaneoussuccesssymposiumsymptom managementtooltrial comparingtumoruser-friendlyvolunteerward

项目摘要

项目成果

ROBERT L COMIS的其他基金

相似基金

相关文献

中文摘要
翻译
描述（由申请人提供）：这笔资金用于支持东部肿瘤合作组织（ECOG）主席Robert L. Comis， M.D.；集团高级科技领导班子；以及Comis博士开发的项目，以提高集团的科学活动和患者收益。这项拨款支持的活动和具体目标是：为ECOG项目提供高质量的高级科学和行政医疗领导，以及支持这种领导的基础设施；加快发展和进行经济合作组研究；提高患者参与ECOG研究的机会。
英文摘要
DESCRIPTION (provided by applicant): This grant is to provide support for the activities of the Eastern Cooperative Oncology Group (ECOG) Chair, Robert L. Comis, M.D.; the senior scientific leadership of the Group; and programs developed by Dr. Comis to enhance the Group's scientific activity and patient accrual. The activities and specific aims supported by this grant are: to provide high quality senior scientific and administrative medical leadership for ECOG programs, and the infrastructure to support that leadership; to expedite the development and conduct of ECOG Studies; and to improve the opportunity for patient participation in ECOG studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ECOG-ACRIN Operations Center
ECOG-ACRIN Operations Center
ECOG-ACRIN Operations Center
ECOG-ACRIN Operations Center
海外基金